Jorge E. Gomez Marin
Research Group on Child Population (IPI), San Juan de Dios University Hospital, Armenia, Quindío, Colombia Study Group on Molecular Parasitology (GEPAMOL), Center for Biomedical Research, University of Quindío, Armenia, Quindío, Colombia
Jaime Castellanos
Director of Virology Laboratory, El Bosque University, Bogotá - Colombia
Alfonso J. Rodriguez-Morales
Public Health and Infection Research, Group Faculty of Health Sciences, Technological University of Pereira, Pereira, Risaralda, Colombia. Biomedicine Research Group, Faculty of Medicine, Autonomous University Foundation of the Americas, Headquarters Pereira, Pereira, Risaralda, Colombia. Public Health and Infection Research, Group Faculty of Health Sciences, Technological University of Pereira, Pereira, Risaralda, Colombia
Jaime A. Cardona-Ospina
Public Health and Infection Research, Group Faculty of Health Sciences, Technological University of Pereira, Pereira, Risaralda, Colombia. Biomedicine Research Group, Faculty of Medicine, Autonomous University Foundation of the Americas, Headquarters Pereira, Pereira, Risaralda, Colombia. Public Health and Infection Research, Group Faculty of Health Sciences, Technological University of Pereira, Pereira, Risaralda, Colombia. Emerging Infections and Tropical Medicine Research Group, Institute for Research in Biomedical Sciences - Sci-Help, Pereira, Risaralda, Colombia.
Jorge Eduardo Forero Duarte
School of Microbiology. Antioquia University Medellin, Colombia
Salim Mattar
University of Cordoba, Tropical Biological Research Institute, Monteria, Colombia
Germán Esparza
Quality assurance program, PROASECA L SAS Colombia
Resumen
A consensus working group formulates recommendations on the criteria to evaluate the diagnostic performance (size and criteria of selection of samples to determine sensitivity, analytical specificity, criteria for limit of detection, criteria for gold standard to evaluate serological assays) that should considered during the evaluation and validation/verification of diagnostic tests for SARS CoV-2 infection. A national external quality control program should be established to guarantee the suitability and performance of these diagnostic serological and molecular tests during this pandemic, that will have deep implications on clinical and public health decisions.
